MGC received legal permission for the sale of cannabis based medicine for medical use in Australia's new market.
MGC Pharma sells MGC Derma business to strategic partners with a five year supply agreement for MGC Pharma's cannabidiol (CBD) and cosmetics raw material to Cannaglobal products.
THC Global Group Ltd (ASX:THC) has signed a supply agreement for formulated medicinal cannabis products with MGC Pharmaceuticals Ltd (ASX:MXC).Under the Agreement, MGC Pharma will provide THC with an immediate supplementary source of medicinal cannabis products, which will be packaged and made available to patients under the Canndeo brand
Ann: Production commenced to support 6000 Australian Patients, page-32
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable